Oui, les groupes de soutien offrent un environnement d'encouragement et de partage d'expériences.
Groupes de soutienIntervention sociale
#5
Combien de temps dure un traitement pour le tabagisme ?
La durée du traitement varie, mais il est souvent recommandé de suivre un programme de plusieurs mois.
Durée du traitementPlan de traitement
Complications
5
#1
Quelles sont les complications du tabagisme ?
Les complications incluent des maladies cardiovasculaires, des cancers et des maladies respiratoires.
Maladies cardiovasculairesCancers
#2
Le tabagisme affecte-t-il la santé mentale ?
Oui, il est associé à des troubles de l'humeur, de l'anxiété et des problèmes de dépendance.
Santé mentaleTroubles de l'humeur
#3
Le tabagisme peut-il entraîner des problèmes de fertilité ?
Oui, il peut réduire la fertilité chez les hommes et les femmes, affectant la reproduction.
FertilitéSanté reproductive
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être réversibles avec l'arrêt du tabac, mais pas toutes.
RéversibilitéArrêt du tabac
#5
Le tabagisme augmente-t-il le risque d'infections ?
Oui, il affaiblit le système immunitaire, augmentant le risque d'infections respiratoires.
Infections respiratoiresSystème immunitaire
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du tabagisme ?
Les facteurs incluent l'exposition à la fumée, l'hérédité et des influences sociales.
Facteurs de risqueExposition à la fumée
#2
L'âge influence-t-il le risque de tabagisme ?
Oui, les jeunes adultes sont plus susceptibles de commencer à fumer en raison de la pression sociale.
ÂgePression sociale
#3
Le stress est-il un facteur de risque ?
Oui, le stress peut inciter à fumer comme moyen de gestion des émotions et de l'anxiété.
StressGestion des émotions
#4
Les antécédents familiaux jouent-ils un rôle ?
Oui, avoir des membres de la famille fumeurs augmente le risque de développer une dépendance.
Antécédents familiauxDépendance au tabac
#5
Les publicités influencent-elles le tabagisme ?
Oui, les publicités peuvent normaliser le tabagisme et inciter les jeunes à commencer à fumer.
PublicitéInfluence sociale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Trouble lié au tabagisme : Questions médicales les plus fréquentes",
"headline": "Trouble lié au tabagisme : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Trouble lié au tabagisme : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-31",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Trouble lié au tabagisme"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles liés à une substance",
"url": "https://questionsmedicales.fr/mesh/D019966",
"about": {
"@type": "MedicalCondition",
"name": "Troubles liés à une substance",
"code": {
"@type": "MedicalCode",
"code": "D019966",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Trouble lié au tabagisme",
"alternateName": "Tobacco Use Disorder",
"code": {
"@type": "MedicalCode",
"code": "D014029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joseph Guydish",
"url": "https://questionsmedicales.fr/author/Joseph%20Guydish",
"affiliation": {
"@type": "Organization",
"name": "Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: joseph.guydish@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Thao Le",
"url": "https://questionsmedicales.fr/author/Thao%20Le",
"affiliation": {
"@type": "Organization",
"name": "Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: thao.le@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Kevin Delucchi",
"url": "https://questionsmedicales.fr/author/Kevin%20Delucchi",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, University of California San Francisco, 401 Parnassus Ave., San Francisco, CA 94143, United States of America. Electronic address: kevin.delucchi@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Guang-Heng Dong",
"url": "https://questionsmedicales.fr/author/Guang-Heng%20Dong",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Yunnan Normal University, Kunming, Yunnan Province, PR China. Electronic address: dongguangheng@ynnu.edu.cn."
}
},
{
"@type": "Person",
"name": "Caravella McCuistian",
"url": "https://questionsmedicales.fr/author/Caravella%20McCuistian",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry and Behavioral Sciences, University of California, San Francisco 1001 Potrero Ave, San Francisco, CA 94110, United States. Electronic address: caravella.mccuistian@ucsf.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37264325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05736-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Placenta Accreta Spectrum.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37290094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000005229"
}
},
{
"@type": "ScholarlyArticle",
"name": "Physiology and Pathophysiology of the Placenta.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37240411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24109066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Preeclamptic Placenta in Whole Slide Images Using Artificial Intelligence Placenta Analysis.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39403751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2024.39.e271"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation of placental thickness and placenta percreta in patients with placenta previa: findings from MRI.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36114883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00261-022-03676-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles liés à une substance",
"item": "https://questionsmedicales.fr/mesh/D019966"
},
{
"@type": "ListItem",
"position": 4,
"name": "Trouble lié au tabagisme",
"item": "https://questionsmedicales.fr/mesh/D014029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Trouble lié au tabagisme - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Trouble lié au tabagisme",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Trouble lié au tabagisme",
"description": "Comment diagnostiquer un trouble lié au tabagisme ?\nQuels critères sont utilisés pour le diagnostic ?\nQui peut poser le diagnostic ?\nY a-t-il des tests spécifiques pour le diagnostic ?\nLe diagnostic peut-il être fait à distance ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Placenta#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Trouble lié au tabagisme",
"description": "Quels sont les symptômes du trouble lié au tabagisme ?\nComment se manifeste le sevrage tabagique ?\nLe tabagisme peut-il affecter l'humeur ?\nY a-t-il des symptômes physiques associés ?\nLes symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Placenta#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Trouble lié au tabagisme",
"description": "Comment prévenir le trouble lié au tabagisme ?\nLes campagnes anti-tabac sont-elles efficaces ?\nQuel rôle jouent les écoles dans la prévention ?\nLes lois anti-tabac aident-elles à réduire la consommation ?\nLes programmes de cessation sont-ils accessibles ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Placenta#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Trouble lié au tabagisme",
"description": "Quels traitements sont disponibles pour le tabagisme ?\nLes médicaments sont-ils efficaces contre le tabagisme ?\nQu'est-ce que la thérapie comportementale ?\nLes groupes de soutien sont-ils utiles ?\nCombien de temps dure un traitement pour le tabagisme ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Placenta#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Trouble lié au tabagisme",
"description": "Quelles sont les complications du tabagisme ?\nLe tabagisme affecte-t-il la santé mentale ?\nLe tabagisme peut-il entraîner des problèmes de fertilité ?\nLes complications sont-elles réversibles ?\nLe tabagisme augmente-t-il le risque d'infections ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Placenta#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Trouble lié au tabagisme",
"description": "Quels sont les principaux facteurs de risque du tabagisme ?\nL'âge influence-t-il le risque de tabagisme ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes publicités influencent-elles le tabagisme ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Placenta#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble lié au tabagisme ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de dépendance."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la consommation régulière, le désir de réduire et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Qui peut poser le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel de santé, comme un médecin ou un psychologue, peut poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests spécifiques pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de tests spécifiques, le diagnostic est basé sur l'entretien clinique."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il être fait à distance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations en ligne peuvent permettre d'évaluer les habitudes de consommation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du trouble lié au tabagisme ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent le besoin urgent de fumer, l'irritabilité et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le sevrage tabagique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sevrage peut provoquer anxiété, dépression, troubles du sommeil et fringales."
}
},
{
"@type": "Question",
"name": "Le tabagisme peut-il affecter l'humeur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut entraîner des fluctuations d'humeur et des troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la toux, l'essoufflement et des douleurs thoraciques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la durée et de l'intensité de la consommation."
}
},
{
"@type": "Question",
"name": "Comment prévenir le trouble lié au tabagisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, la sensibilisation et des politiques anti-tabac efficaces."
}
},
{
"@type": "Question",
"name": "Les campagnes anti-tabac sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sensibilisent le public aux dangers du tabagisme et encouragent l'arrêt."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les écoles dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les écoles peuvent éduquer les jeunes sur les dangers du tabac et promouvoir des modes de vie sains."
}
},
{
"@type": "Question",
"name": "Les lois anti-tabac aident-elles à réduire la consommation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lois strictes sur la vente et la consommation de tabac réduisent son usage."
}
},
{
"@type": "Question",
"name": "Les programmes de cessation sont-ils accessibles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux programmes de cessation sont disponibles dans les centres de santé et en ligne."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le tabagisme ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils efficaces contre le tabagisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme la varénicline et le bupropion sont efficaces pour réduire le besoin de fumer."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie comportementale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une approche qui aide à modifier les comportements liés à la consommation de tabac."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un environnement d'encouragement et de partage d'expériences."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement pour le tabagisme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais il est souvent recommandé de suivre un programme de plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du tabagisme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies cardiovasculaires, des cancers et des maladies respiratoires."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est associé à des troubles de l'humeur, de l'anxiété et des problèmes de dépendance."
}
},
{
"@type": "Question",
"name": "Le tabagisme peut-il entraîner des problèmes de fertilité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut réduire la fertilité chez les hommes et les femmes, affectant la reproduction."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec l'arrêt du tabac, mais pas toutes."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque d'infections ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il affaiblit le système immunitaire, augmentant le risque d'infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du tabagisme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à la fumée, l'hérédité et des influences sociales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de tabagisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes sont plus susceptibles de commencer à fumer en raison de la pression sociale."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut inciter à fumer comme moyen de gestion des émotions et de l'anxiété."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des membres de la famille fumeurs augmente le risque de développer une dépendance."
}
},
{
"@type": "Question",
"name": "Les publicités influencent-elles le tabagisme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les publicités peuvent normaliser le tabagisme et inciter les jeunes à commencer à fumer."
}
}
]
}
]
}
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: joseph.guydish@ucsf.edu.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: thao.le@ucsf.edu.
Department of Psychiatry, University of California San Francisco, 401 Parnassus Ave., San Francisco, CA 94143, United States of America. Electronic address: kevin.delucchi@ucsf.edu.
Department of Psychiatry and Behavioral Sciences, University of California, San Francisco 1001 Potrero Ave, San Francisco, CA 94110, United States. Electronic address: caravella.mccuistian@ucsf.edu.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA, 94118, United States. Electronic address: kwinoja.kapiteni@ucsf.edu.
OHSU/PSU School of Public Health, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239-3098, United States. Electronic address: drbarbaracampbell@earthlink.net.
Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan; School of Nursing, University of Michigan, Ann Arbor, Michigan.
Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan; School of Nursing, University of Michigan, Ann Arbor, Michigan; Addiction Center, Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
To evaluate the effect of placental location on the severity of placenta accreta spectrum (PAS)....
We analyzed 390 patients with placenta previa combined with placenta accreta spectrum who underwent cesarean section between January 1, 2014 and December 30, 2020 in the electronic case database of th...
The history of cesarean delivery rates in the anterior group (91.67%) and the non-central group (85.71%) were statistically different from the posterior group (63.74%)(P < 0.001). Univariate logistic ...
Compared with posterior placenta, anterior and non-central placenta are independent risk factors for invasive PAS in patients with placenta previa, during which we should be more cautious in treatment...
Placenta accreta spectrum (PAS) is one of the most dangerous conditions in pregnancy and is increasing in frequency. The risk of life-threatening bleeding is present throughout pregnancy but is partic...
Preeclampsia (PE) is a hypertensive pregnancy disorder linked to placental dysfunction, often involving pathological lesions like acute atherosis, decidual vasculopathy, accelerated villous maturation...
A total of 168 placental whole-slide images (WSIs) of patients from Seoul National University Hospital (comprising 84 PE cases and 84 normal controls) were used for model development and internal vali...
Using ensemble modeling, we developed a model to identify PE placentas. The model showed good performance (area under the precision-recall curve [AUPRC], 0.771; 95% confidence interval [CI], 0.752-0.7...
The proposed computational pathology model demonstrated a strong ability to identify preeclamptic placentas. Computational pathology has the potential to improve the identification of PE placentas....
This study aimed to identify if placental thickness measured from MRI images correlated with placenta percreta in patients with placenta previa....
Placental thickness was retrospectively measured in 161 patients from July 2018 to August 2020. The measurements were performed at the thickest part of the placenta in the lower uterine segment on the...
Placental thickness in patients with placenta percreta was significantly higher than in patients with placenta increta, placenta accreta, and normal placentas (p < 0.05). Multivariate analysis reveale...
Patients with placenta percreta had the highest placental thickness. Placental thickness was correlated with placenta percreta....
The objective of this study was to assess the performance of ultrasound and magnetic resonance imaging (MRI) features in helping to classify the type of placenta accreta spectrum (PAS; accreta/increta...
We conducted a retrospective study in 82 pregnant women with PAS who underwent ultrasound and MRI examination of the pelvis before delivery (from an initial cohort of 185 women with PAS). We estimated...
Among the 82 patients, 29 (35%) had placenta accreta/increta and 53 (65%) had placenta percreta. The best features to discriminate between placenta accreta/increta and placenta percreta with ultrasoun...
The nomogram we developed to predict the risk of placenta percreta among patients with PAS had good discriminative capabilities. This performance and its impact on maternal morbidity should be confirm...
Although historically pre-eclampsia, preterm birth, abruption, fetal growth restriction and stillbirth have been viewed as clinically distinct entities, a growing body of literature has demonstrated t...
Placental accreta spectrum (PAS) disorder with bladder involvement can be associated with maternal and neonatal morbidity. Magnetic resonance imaging (MRI) may provide accurate preoperative diagnoses....
This study had 2 aims: to retrospectively review the MRI findings for bladder involvement in PAS with placental previa and to correlate bladder involvement with maternal and neonatal outcomes....
MRI images of 48 patients with severe PAS (increta and percreta) with placenta previa/low-lying placenta were evaluated by 2 experienced radiologists blinded to the final diagnoses. Nine MRI findings ...
Of the 48 patients, 27 did not have bladder involvement, while 21 did. Logistic regression analysis identified 2 predictive MRI features for bladder involvement. They were abnormal vascularization (OR...
PAS with bladder involvement was significantly correlated with massive surgical blood loss. Prenatally, the disorder was predicted with high specificity by the combination of loss of chemical shift ar...
To determine the rate of resolution of placenta previa and low-lying placenta (LLP) and the effect of pelvic rest recommendations on the timing of follow-up imaging....
Retrospective review of pregnancies with previa/LLP detected on mid-trimester exam at our ultrasound unit from 2019 to 2021. LLP was defined as the lower edge of placenta located within 2 cm of the in...
Exactly 144 patients had previa and 266 had LLP on the mid-trimester exam with complete records. Previa resolution happened in 51.4% (74/144) of cases. Exactly 62% (46/74) of previa resolutions occurr...
Most societies recommend follow-up imaging at 32 weeks; however, our results suggest this may be done sooner and closer to 28 weeks. Pelvic rest did not affect timing of repeat imaging or delivery....
To determine whether women who experience resolution of low placentation (low-lying placenta or placenta previa) are at increased risk of postpartum hemorrhage compared to those with normal placentati...
This was a retrospective cohort study of women who delivered at Mount Sinai Hospital between 2015 and 2019, and who were diagnosed with low-lying placenta or placenta previa on transvaginal ultrasound...
A total of 1256 women were identified for analysis, of whom 628 had resolved low placentation and 628 had normal placentation. Women with resolved low placentation, compared to those with normal place...
Despite high rates of resolution of low-lying placenta and placenta previa by term, women with resolved low placentation remain at increased risk of postpartum hemorrhage compared to those with normal...